IRVINE, Calif. — October 9, 2025 — Leads & Copy — Toro Neurovascular, a company specializing in advanced catheter technologies for neurovascular intervention, has announced an exclusive distribution partnership with Kaneka Medical America for Toro’s neurovascular catheter portfolio in the U.S. market, pending regulatory clearance.
According to Hyung Posalit, CEO of Toro Neurovascular, the partnership with Kaneka will speed up Toro’s mission to provide physicians with tools that make challenging neurovascular procedures more predictable and controlled. He added that Kaneka’s strong commercial infrastructure and shared commitment to clinical excellence make them an ideal partner to bring their technology to market swiftly and at scale.
The collaboration will bring Toro’s next-generation catheter platform to clinicians treating ischemic and hemorrhagic stroke across the United States. Toro’s catheter platform is engineered for trackability, distal support, and stability during complex interventions and is designed to address unmet clinical needs with a focus on performance, deliverability, and versatility across a wide range of neurovascular interventions.
Ken Toda, President of Kaneka Medical America, said that Toro’s catheter technologies complement and strengthen their existing neurovascular portfolio, giving them the opportunity to offer a broader spectrum of solutions to patients suffering from neurovascular disease, and that they aim to deliver innovations that help improve procedural precision and patient care.
Rob Abrams, Chief Strategy Officer for Kaneka Medical America, added that the partnership with Toro reflects Kaneka’s culture of innovation and shared commitment to lasting impact in neurovascular care.
Toro has appointed Marc Paris as Chief Commercial Officer to strengthen its commercialization efforts. Paris will oversee market launch strategy in collaboration with Kaneka.
Contact: info@toroneuro.com
Source: Toro Neurovascular
